We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




Silicone Oil Helps Shield Vision During Radiation Therapy for Eye Cancer

By MedImaging International staff writers
Posted on 22 Jul 2010
Print article
A commonly used substance called silicone oil could protect vision in patients undergoing radiation therapy for ocular melanoma.

Researchers at the University of California, Los Angeles (UCLA; USA) examined several vitreous substitutes, including silicone oil, heavy oil, and perfluorocarbon (PFC) for their radiation attenuation properties from iodine 125, using both empirical measurement and theoretical calculation. In vitro and ex vivo cadaveric dosimetry measurements were obtained with thermo-luminescent dosimeters to demonstrate the attenuation effect during simulated plaque brachytherapy. The results showed that radiation attenuation using the silicone oil at distances corresponding to vital ocular structures achieved the best results, with a projected attenuation reaching as high as 57%.

Based on these results, the researchers developed a new surgical technique, which takes place immediately before the patient's eye is exposed to the radiation. The patients first undergo an exam to measure baseline vision before treatment. The surgeon next removes the vitreous gel, which supports the interior shape of the eye; the gel is replaced with silicon oil, a substance that is often used to hold the retina in place during surgery to repair retinal detachment. The surgeons then treat the ocular melanoma by stitching a gold plaque containing radioactive seeds to the sclera of the eye, removing it a few days later; after removing the radiation plaque from the treated eye, the oil is flushed away with saline, which is eventually replaced by the patient's natural fluids. The study was published in the July 2010 issue of Archives of Ophthalmology.

"Until recently, physicians focused on killing the tumor and considered vision loss secondary. Our results suggest that silicon oil offers a safe tool for protecting the patient's vision during radiation,” said lead author Tara McCannel, M.D., an assistant professor of ophthalmology and director of the UCLA ophthalmic oncology center. "The substance acts like a physical shield, reducing the amount of radioactive rays that reach the back and sides of the eye. We hope that silicon oil's ability to block radiation translates into better vision for patients down the road.”

While radiation treatment for ocular melanoma kills the cancer cells, it also causes irreversible injury to the optic nerve fibers and macula, the section of the retina responsible for central vision; the radiation damage to the macula also weakens the blood vessels supplying the eye. Even when the radiation treatment is successful, the eye structures remain extremely fragile and prone to atrophy, which can lead to subsequent vision loss.

Related Links:

University of California, Los Angeles


Digital Radiographic System
OMNERA 300M
New
Prostate Cancer MRI Analysis Tool
DynaCAD Urology
Computed Tomography System
Aquilion ONE / INSIGHT Edition
Digital X-Ray Detector Panel
Acuity G4

Print article

Channels

Radiography

view channel
Image: AI can identify “mammographically-visible” types of interval cancers earlier by flagging them at the time of screening (Photo courtesy of ScreenPoint Medical)

AI Improves Early Detection of Interval Breast Cancers

Interval breast cancers, which occur between routine screenings, are easier to treat when detected earlier. Early detection can reduce the need for aggressive treatments and improve the chances of better outcomes.... Read more

Nuclear Medicine

view channel
Image: In vivo imaging of U-87 MG xenograft model with varying mass doses of 89Zr-labeled KLG-3 or isotype control (Photo courtesy of L Gajecki et al.; doi.org/10.2967/jnumed.124.268762)

Novel Radiolabeled Antibody Improves Diagnosis and Treatment of Solid Tumors

Interleukin-13 receptor α-2 (IL13Rα2) is a cell surface receptor commonly found in solid tumors such as glioblastoma, melanoma, and breast cancer. It is minimally expressed in normal tissues, making it... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.